Commentary

Podcast

Advancing the optimal diagnosis & treatment of thyroid eye disease

In this PER On Air Ophthalmology Times podcast, an expert panel discusses diagnosing TED and providing appropriate pharmacologic and surgical treatments.

Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics

Thyroid eye disease is a condition frequently associated with Graves disease that involves both acute and chronic inflammation of the orbit. Patients may experience ocular discomfort, appearance changes, and vision loss. In this podcast, an expert panel discusses diagnosing TED and providing appropriate pharmacologic and surgical treatments. 

Wendy W. Lee, MD

Professor of Clinical Ophthalmology and Dermatology
Oculofacial Plastic & Reconstructive Surgery, Orbit and Oncology
Bascom Palmer Eye Institute
University of Miami Miller School of Medicine, Miami, FL

Chris R. Alabiad, MD

Assistant Dean for Student Affairs
Ophthalmology Residency Program Director
Professor of Clinical Ophthalmology
Oculofacial Plastic & Reconstructive Surgery and Orbital Oncology
Bascom Palmer Eye Institute/Miami Veterans Affairs Hospital
University of Miami Miller School of Medicine, Miami, FL

Katherine Rachon, OD, FAAO, Dipl ABO

Residency Director
Virginia Eye Consultants
Hampton, VA

Ana Carolina Victoria, MD, FACS

Oculofacial Plastic and Reconstructive Surgery
Center for Excellence in Eye Care
Miami, FL

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Eric D. Donnenfeld, MD, on the effect of lifitegrast clinical signs and biomarkers in dry eye disease
(Image credit: Ophthalmology Times) The Residency Report: Clinical insights from the iStent infinite trial
(Image credit: Ophthalmology Times) ASCRS 2025: Amar Shah, MD, on why hyperosmolar tear film before and after cataract surgery matters
(Image credit: Ophthalmology Times) ASCRS 2025: Jason Bacharach, MD, on early-onset efficacy with perfluorohexyloctane in dry eye
© 2025 MJH Life Sciences

All rights reserved.